Journal du commerce, de politique et de littérature

1818/06/19 (Numéro 331).

Lixiviação de glyphosate e imazapyr em solos com diferentes texturas e composição química: I - método do bioensaio

A mobilidade dos herbicidas no perfil do solo é influenciada por vários processos, tais como, retenção, transformação e transporte. O conhecimento destes fenômenos é fundamental para a perfeita compreensão do destino de tais produtos no ambiente. Dentre as várias técnicas utilizadas nesses estudos, o método do bioensaio apresenta-se como de ótima representatividade e reprodutibilidade. Em razão dessas características, associadas a poucas informações sobre a mobilidade de herbicidas nos solos sob condições tropicais, foi conduzido um bioensaio objetivando verificar o movimento vertical do glyphosate e do imazapyr, em colunas de solos de diferentes texturas e composição química, utilizando-se o tomateiro (Lycopersicon esculentum Mill var. Santa Clara) como planta-teste. Os resultados desse estudo permitiram concluir que: a) o limite de detecção do bioensaio para o glyphosate e para o imazapyr corresponde ao menor valor de I50, obtido na curva padrão, 331,52 e 5,4 µg L-1, respectivamente; b) as concentrações do glyphosate biologicamente ativo nos lixiviados dos solos de Viçosa e de Sabará encontram-se abaixo do limite de detecção do bioensaio; c) o glyphosate apresentou, na coluna de 1 cm, mobilidade muito baixa nos solos estudados; d) a mobilidade do imazapyr, na coluna de 30 cm, é maior no solo de textura francoarenosa de Viçosa; e) o alto teor de argila e de matéria orgânica do solo de Sabará apresentam-se como os principais fatores de retenção do imazapyr nesse solo.

A novel polymorphism in the coding region of the vasopressin type 2 receptor gene

Nephrogenic diabetes insipidus (NDI) is a rare disease characterized by renal inability to respond properly to arginine vasopressin due to mutations in the vasopressin type 2 receptor (V2(R)) gene in affected kindreds. In most kindreds thus far reported, the mode of inheritance follows an X chromosome-linked recessive pattern although autosomal-dominant and autosomal-recessive modes of inheritance have also been described. Studies demonstrating mutations in the V2(R) gene in affected kindreds that modify the receptor structure, resulting in a dys- or nonfunctional receptor have been described, but phenotypically indistinguishable NDI patients with a structurally normal V2(R) gene have also been reported. In the present study, we analyzed exon 3 of the V2(R) gene in 20 unrelated individuals by direct sequencing. A C®T alteration in the third position of codon 331 (AGC®AGT), which did not alter the encoded amino acid, was found in nine individuals, including two unrelated patients with NDI. Taken together, these observations emphasize the molecular heterogeneity of a phenotypically homogeneous syndrome

Jätteenpolton tulevaisuus Suomessa

Vuonna 2013 Suomessa astui voimaan Valtioneuvoston asetus kaatopaikoista 331/2013. Siinä asetettiin muun muassa rajoituksia orgaanisen ja biohajoavan aineksen sijoittamisesta kaatopaikoille. Tämä rajoitus astuu voimaan 1. tammikuuta 2016 alkaen, josta lähtien kaatopaikoille sijoitettava jäte ei saa sisältää yli 10 prosenttia orgaanista tai biohajoaaa ainesta. Asetus aiheutti muutos paineen Suomen jätesektorille, jossa perinteisesti oltiin suurin osa jätteestä sijoitettu kaatopaikoille. Edelleen suurin osa syntyvistä jätteistä sijoitetaan kaatopaikoille, mutta yhdyskuntajätteen energiahyödyntäminen on kasvattanut roolia huomattavasti. Kun 2000-luvun alussa Suomen jätteenpolttolaitosten kapasiteetti oli vielä 50 000 tonnia jätettä vuodessa, on kapasiteetti vuonna 2016 lähes 1,7 miljoonaa tonnia. Vuonna 2016 Suomessa on yhdeksän toiminnassa olevaa jätteenpolttolaitosta ja työn tarkasteluhetkellä uusia ei ole suunnitteilla. On todennäköistä, ettei jätteenpolttolaitosten kapasitetti nouse enää huomattavasti, koska poltettavan jätteen määrä on rajallinen ja kapasiteetin nostaminen vaatisi jätteen tuomista muualta.

Fludarabine induces apoptosis in chronic lymphocytic leukemia - the role of P53, Bcl-2, Bax, Mcl-1, and Bag-1 proteins

The expression of P53, Bcl-2, Bax, Bag-1, and Mcl-1 proteins in CD5/CD20-positive B-chronic lymphocytic leukemia (B-CLL) cells from 30 typical CLL patients was evaluated before and after 48 h of incubation with 10-6 M fludarabine using multiparametric flow cytometric analysis. Protein expression was correlated with annexin V expression, Rai modified clinical staging, lymphocyte doubling time, and previous treatment. Our main goal was to determine the predictive value of these proteins in CLL cells in terms of disease evolution. Bcl-2 expression decreased from a median fluorescence index (MFI) of 331.71 ± 42.2 to 245.81 ± 52.2 (P < 0.001) after fludarabine treatment, but there was no difference between viable cells (331.57 ± 44.6 MFI) and apoptotic cells (331.71 ± 42.2 MFI) before incubation (P = 0.859). Bax expression was higher in viable cells (156.24 ± 32.2 MFI) than in apoptotic cells (133.56 ± 35.7 MFI) before incubation, probably reflecting defective apoptosis in CLL (P = 0.001). Mcl-1 expression was increased in fludarabine-resistant cells and seemed to be a remarkable protein for the inhibition of the apoptotic process in CLL (from 233.59 ± 29.8 to 252.04 ± 35.5; P = 0.033). After fludarabine treatment, Bag-1 expression was increased in fludarabine-resistant cells (from 425.55 ± 39.3 to 447.49 ± 34.5 MFI, P = 0.012), and interestingly, this higher expression occurred in patients who had a short lymphocyte doubling time (P = 0.022). Therefore, we could assume that Bag-1 expression in such situation might identify CLL patients who will need treatment earlier.

miRNA expression profiles in chronic lymphocytic and acute lymphocytic leukemia

MicroRNAs (miRNAs) are a class of small endogenous RNAs that play important regulatory roles by targeting mRNAs for cleavage or translational repression. miRNAs act in diverse biological processes including development, cell growth, apoptosis, and hematopoiesis, suggesting their association with cancer. We determined the miRNA expression profile of chronic and acute lymphocytic leukemias (CLL and ALL) using the TaqMan® MicroRNA Assays Human Panel (Applied Biosystems). Pooled leukemia samples were compared to pooled CD19+ samples from healthy individuals (calibrator) by the 2-DDCt method. Total RNA input was normalized based on the Ct values obtained for hsa-miR-30b. The five most highly expressed miRNAs were miR-128b, miR-204, miR-218, miR-331, and miR-181b-1 in ALL, and miR-331, miR-29a, miR-195, miR-34a, and miR-29c in CLL. To our knowledge, this is the first report associating miR-128b, miR-204 and miR-331 to hematological malignancies. The miR-17-92 cluster was also found to be up-regulated in ALL, as previously reported for some types of lymphomas. The differences observed in gene expression levels were validated for miR-331 and miR-128b in ALL and CD19+ samples. These miRNAs were up-regulated in ALL, in agreement with our initial results. A brief target analysis was performed for miR-331. One of its putative targets, SOCS1, promotes STAT activation, which is a known mediator of cell proliferation and survival, suggesting the possibility of an association between miR-331 and these processes. This initial screening provided information on miRNA differentially expressed in normal and malignant B-cells that could suggest the potential roles of these miRNAs in hematopoiesis and leukemogenesis.

Lingvarum ebraeae et finnicae convenientia

Variantti A.